Lupus nephritis: redefining the treatment goals.
De Vriese AS, Sethi S, Fervenza FC.
Kidney Int. 2025 Feb;107(2):198-211. doi: 10.1016/j.kint.2024.10.018. Epub 2024 Nov 8.
Post-infectious glomerulonephritis.
Balasubramanian R, Marks SD.
Paediatr Int Child Health. 2017 Nov;37(4):240-247. doi: 10.1080/20469047.2017.1369642. Epub 2017 Sep 11.
Tubulointerstitial nephritis: diagnosis, treatment, and monitoring.
Joyce E, Glasner P, Ranganathan S, Swiatecka-Urban A.
Pediatr Nephrol. 2017 Apr;32(4):577-587. doi: 10.1007/s00467-016-3394-5. Epub 2016 May 7.
Infectious complications in lupus nephritis treatment: a systematic review and meta-analysis.
Thong KM, Chan TM.
Lupus. 2019 Mar;28(3):334-346. doi: 10.1177/0961203319829817. Epub 2019 Feb 11.
Lupus Nephritis.
Wenderfer SE, Eldin KW.
Pediatr Clin North Am. 2019 Feb;66(1):87-99. doi: 10.1016/j.pcl.2018.08.007.
[Infectious tubulo-interstitial nephritis].
Yamabe H.
Nihon Naika Gakkai Zasshi. 1999 Aug 10;88(8):1435-8.
Biological drugs for systemic lupus erythematosus or active lupus nephritis and rates of infectious complications. Evidence from large clinical trials.
Steiger S, Ehreiser L, Anders J, Anders HJ.
Front Immunol. 2022 Sep 23;13:999704. doi: 10.3389/fimmu.2022.999704. eCollection 2022.
Acute interstitial nephritis secondary to infectious mononucleosis.
Verma N, Arunabh S, Brady TM, Charytan C.
Clin Nephrol. 2002 Aug;58(2):151-4. doi: 10.5414/cnp58151.
[Lupus nephritis: up-to-date].
Karras A.
Rev Med Interne. 2015 Feb;36(2):98-106. doi: 10.1016/j.revmed.2014.09.006. Epub 2014 Oct 13.
Nephritis in infectious mononucleosis.
[No authors listed]
Lancet. 1973 Mar 24;1(7804):647-8.
